LCA-0061Single Ascending and Multiple Ascending Dose Study of LCA-0061

Sponsor:

Lycia Therapeutics, Inc.

Code:

NCT07701954

Conditions

Atopic Disease

Peanut Allergies

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

LCA-0061

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Lycia Therapeutics, Inc. on 2026-07-14.